Bill
Bill > SB787
MD SB787
MD SB787Managed Care Organizations and Health Insurance Carriers - Prior Authorization for HIV Postexposure Prophylaxis for Victims of Sexual Offenses - Prohibition
summary
Introduced
02/07/2022
02/07/2022
In Committee
02/07/2022
02/07/2022
Crossed Over
Passed
Dead
04/11/2022
04/11/2022
Introduced Session
2022 Regular Session
Bill Summary
Prohibiting managed care organizations and certain insurers, nonprofit health service plans, and health maintenance organizations from applying a prior authorization requirement for prescription drugs used as postexposure prophylaxis for the prevention of HIV if the drug is prescribed to a victim of an alleged rape or sexual offense.
AI Summary
This bill prohibits managed care organizations, insurers, nonprofit health service plans, and health maintenance organizations from applying a prior authorization requirement for prescription drugs used as postexposure prophylaxis for the prevention of HIV if the drug is prescribed to a victim of an alleged rape or sexual offense. The bill applies to all policies, contracts, and health benefit plans issued, delivered, or renewed in the state of Maryland on or after January 1, 2023, and takes effect on January 1, 2023.
Committee Categories
Budget and Finance
Sponsors (1)
Last Action
Senate Finance Hearing (13:00 2/23/2022 ) (on 02/23/2022)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0787?ys=2022RS |
| BillText | https://mgaleg.maryland.gov/2022RS/bills/sb/sb0787f.pdf |
Loading...